Table 1.
Patient | Sex | Age, y | FV level, % | Coinherited thrombophilic defects | Clinical phenotype* |
---|---|---|---|---|---|
PD I | F | 64 | < 0.5 | Moderate/severe (5) | |
PD II | F | 44 | < 0.5 | 170% FVIII | Severe (7) |
PD III | F | 35 | 0.6 | 131% PT (no F2 G20210A) | Asymptomatic (0†) |
PD IV | F | 27 | < 0.5 | Mild (2) | |
PD V | F | 52 | < 0.5 | Severe (10†) | |
PD VI | M | 28 | < 0.5 | Mild (1†) | |
PD VII | F | 62 | 4.8 | Mild (1) | |
PD VII-A | F | 46 | 6.2 | Mild (1) | |
GK 502 | F | 57 | < 0.5 | Mild | |
GK 505 | F | 56 | < 0.5 | 53% PC | Unknown |
GK 506 | M | 65 | < 0.5 | Unknown |
PT indicates prothrombin; and PC, protein C.
Numbers in parentheses represent the bleeding score calculated according to Rodeghiero et al.29
Prophylaxis (with plasma and/or antifibrinolytic agents) often given during risk situations after the diagnosis of severe FV deficiency was made.